About this trial
The goals of this observational study is to assess whether a new advanced wireless skin sensor vital sign monitoring system can effectively monitor the vital signs of healthy newborn infants (≥ 35 weeks gestational age). The main aims of this Study are to:
1. Assess feasibility 2. Evaluate safety 3. Determine accuracy of the wireless monitoring system, compared to the standard of care wired vital sign monitoring system, immediately after delivery and for the first 2h of age in the obstetrical center under unsupervised parents' care. The newborn infants participating in the Study will have both vital sign monitoring systems placed on their chest and limb. Their vital signs will be monitored for 2h consecutively.
Eligibility criteria
Qualifiers
Newborns ≥35 weeks (gestational age)
Newborns determined to be clinically stable at delivery
Newborns with no skin abnormalities
Disqualifiers
Newborns ≤ 35 weeks (gestational age)
Newborns determined to not be clinically stable at delivery
Newborns with Skin abnormalities
Trial design
Treatments tested in this trial
- Wireless skin sensors vital sign monitoring system
- Wired vital sign monitoring system
Treatment groups
Sponsors and collaborators
Guilherme Sant'Anna, MD
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Sponsor institution
Hospital Universitário da Universidade Estadual de Londrina
Collaborator
Nuovo Ospedale degli Infermi
Collaborator
Luzerner Kantonsspital
Collaborator